1. Home
  2. NTWK vs INMB Comparison

NTWK vs INMB Comparison

Compare NTWK & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTWK
  • INMB
  • Stock Information
  • Founded
  • NTWK 1997
  • INMB 2015
  • Country
  • NTWK United States
  • INMB United States
  • Employees
  • NTWK N/A
  • INMB N/A
  • Industry
  • NTWK Computer Software: Prepackaged Software
  • INMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTWK Technology
  • INMB Health Care
  • Exchange
  • NTWK Nasdaq
  • INMB Nasdaq
  • Market Cap
  • NTWK 56.1M
  • INMB 49.2M
  • IPO Year
  • NTWK 1998
  • INMB 2019
  • Fundamental
  • Price
  • NTWK $4.05
  • INMB $1.69
  • Analyst Decision
  • NTWK
  • INMB Hold
  • Analyst Count
  • NTWK 0
  • INMB 3
  • Target Price
  • NTWK N/A
  • INMB $4.30
  • AVG Volume (30 Days)
  • NTWK 65.0K
  • INMB 333.9K
  • Earning Date
  • NTWK 11-11-2025
  • INMB 10-30-2025
  • Dividend Yield
  • NTWK N/A
  • INMB N/A
  • EPS Growth
  • NTWK 316.67
  • INMB N/A
  • EPS
  • NTWK 0.25
  • INMB N/A
  • Revenue
  • NTWK $66,088,229.00
  • INMB $50,000.00
  • Revenue This Year
  • NTWK N/A
  • INMB $264.29
  • Revenue Next Year
  • NTWK N/A
  • INMB $9,819.61
  • P/E Ratio
  • NTWK $16.36
  • INMB N/A
  • Revenue Growth
  • NTWK 7.65
  • INMB 19.05
  • 52 Week Low
  • NTWK $2.14
  • INMB $1.69
  • 52 Week High
  • NTWK $5.75
  • INMB $11.64
  • Technical
  • Relative Strength Index (RSI)
  • NTWK 38.06
  • INMB 38.60
  • Support Level
  • NTWK $3.90
  • INMB $1.73
  • Resistance Level
  • NTWK $4.21
  • INMB $1.93
  • Average True Range (ATR)
  • NTWK 0.25
  • INMB 0.10
  • MACD
  • NTWK -0.05
  • INMB -0.00
  • Stochastic Oscillator
  • NTWK 15.00
  • INMB 5.45

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

About INMB INmune Bio Inc. Common stock

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.

Share on Social Networks: